Anesthetic Efficacy of 1.8 ml Versus 3.6 ml of 4% Articaine Buccal Infiltration

Launched by CAIRO UNIVERSITY · Nov 3, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how effective different amounts of a local anesthetic called articaine are in numbing pain in patients with a specific dental condition known as symptomatic irreversible pulpitis. The researchers want to compare the effectiveness of two doses: 1.8 ml and 3.6 ml. They will look at how well each dose works and whether patients need any extra anesthesia during their dental treatment.

To participate in this study, patients should be generally healthy and fit into certain health categories defined by the American Society of Anesthesiologists. They need to be experiencing dental pain from irreversible pulpitis and be able to communicate their pain levels. However, individuals with allergies to the medications, pregnant or breastfeeding women, those who have taken pain medications recently, or those with more than one painful tooth in the same area won’t be eligible. If you join the study, you can expect to receive one of the two doses of articaine, and your pain relief will be monitored. This research could help improve dental care for patients dealing with similar issues in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Healthy patients who are categorized as I or II according to The American Society of Anesthesiologists (ASA class I or II).
• • 2. No sex predilection
• • 3. Patients with symptomatic irreversible pulpitis
• • 4. Patient with the ability to understand and use pain scales.
• • 5. Patients who accept to enroll in the study.
• Exclusion Criteria:
• • 1. Patients' allergies to any of the drugs or materials used in the study.
• • 2. Pregnant and lactating females.
• • 3. Patients taking analgesics in the last 6-8 hours.
• • 4. Patients having more than one symptomatic tooth in the same quadrant